Precautions when taking afatinib: Is it best to take it before or after meals?

Afatinib is an irreversible oral epidermal growth factor receptor (EGFR) inhibitor commonly used to treat EGFR mutation-positive non-small cell lung cancer (NSCLC) patients. Since its absorption and metabolism are significantly affected by the gastrointestinal environment, the correct medication time plays a key role in maintaining drug efficacy and controlling side effects. According to international authoritative drug instructions and clinical pharmacokinetic studies, afatinib should be taken on an empty stomach, that is, at least 1 hour before a meal or at least 2 hours after a meal to ensure maximum absorption rate.

This is because afatinib is more stable and has higher bioavailability on an empty stomach, and food may reduce its blood concentration, thereby affecting its inhibitory strength on theEGFR mutation pathway in the body. If taken immediately after a meal, the food will delay gastric emptying and affect intestinal absorption, which may lead to a weakening of the drug's efficacy and thus affect tumor control. In addition, taking it on an empty stomach can also reduce the occurrence of gastrointestinal side effects such as stomach discomfort and nausea, which is especially important during the first use stage.

Patients should develop a fixed medication habit while taking afatinib, such as taking the medication on an empty stomach every morning after getting up, and waiting at least one hour after taking the medication before eating to ensure full absorption of the medication. During medication, you should avoid ingesting grapefruit juice and other foods or drinks that affect the metabolism of liver drug enzymes at the same time to prevent abnormal increase or decrease in blood drug concentration.

In addition, it is recommended to drink plenty of water while taking the drug and avoid taking antacids containing magnesium and aluminum at the same time or other drugs that may affect the gastric acid environment. If combined use is required, it should be staggered with afatinib for more than 2 hours. If patients need to take stomach medicine due to gastrointestinal discomfort, be sure to consult a professional doctor to avoid drug interactions.

In short, the principle of taking afatinib on an empty stomach should be strictly observed, which is the basis for ensuring its efficacy and safety, and is also the core link to improve treatment compliance.

Reference materials:https://www.giotrif.com/